Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H6O |
Molecular Weight | 46.0684 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCO
InChI
InChIKey=LFQSCWFLJHTTHZ-UHFFFAOYSA-N
InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3
Molecular Formula | C2H6O |
Molecular Weight | 46.0684 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9880479Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021074Orig1s010lbl.pdf
https://www.ncbi.nlm.nih.gov/pubmed/17591544
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9880479
Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021074Orig1s010lbl.pdf
https://www.ncbi.nlm.nih.gov/pubmed/17591544
Alcohols exhibit rapid broad-spectrum antimicrobial activity against vegetative bacteria (including mycobacteria), viruses, and fungi but are not sporicidal. They are, however, known to inhibit sporulation and spore germination, but this effect is reversible. Because of the lack of sporicidal activity, alcohols are not recommended for sterilization but are widely used for both hard-surface disinfection and skin antisepsis. Lower concentrations may also be used as preservatives and to potentiate the activity of other biocides. Many alcohol products include low levels of other biocides (in particular chlorhexidine), which remain on the skin following evaporation of the alcohol, or excipients (including emollients), which decrease the evaporation time of the alcohol and can significantly increase product efficacy. Ethanol in combination with: chlorhexidine gluconate 1% was approved to use in surgical hand antiseptic. It significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care. Ethanol is also used as a co-solvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol is metabolized by the hepatic enzyme alcohol dehydrogenase. Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1962 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17591544 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | AVAGARD Approved UseSurgical hand antiseptic: Significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care Launch Date2001 |
PubMed
Title | Date | PubMed |
---|---|---|
[Opioid receptor knockout mice]. | 1999 Dec |
|
Central leptin and cholecystokinin in gastroprotection against ethanol-induced damage. | 2000 |
|
Sex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal in rats. | 2000 Apr |
|
Ethanol and murine interleukin (IL)-12 production. | 2000 Apr |
|
Roles of tissue transglutaminase in ethanol-induced inhibition of hepatocyte proliferation and alpha 1-adrenergic signal transduction. | 2000 Jul 21 |
|
Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. | 2000 Jun |
|
Replenishment of glutathione levels improves mucosal function in experimental acute colitis. | 2000 May |
|
Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse. | 2000 May 12 |
|
Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice. | 2000 Oct 15 |
|
Generalisation of ethanol with drug mixtures containing a positive modulator of the GABA(A) receptor and an NMDA antagonist. | 2001 |
|
Bacterial release of arsenic ions and organoarsenic compounds from soil contaminated by chemical warfare agents. | 2001 Feb |
|
Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity. | 2001 Feb 16 |
|
A novel alcohol oxidase/RNA-binding protein with affinity for mycovirus double-stranded RNA from the filamentous fungus Helminthosporium (Cochliobolus) victoriae: molecular and functional characterization. | 2001 Feb 16 |
|
Peroxisomal remnant structures in Hansenula polymorpha Pex5 cells can develop into normal peroxisomes upon induction of the PTS2 protein amine oxidase. | 2001 Feb 9 |
|
Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State. | 2001 Jan |
|
Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions. | 2001 Jan |
|
Severe ethylene glycol ingestion treated without hemodialysis. | 2001 Jan |
|
Fomepizole in the treatment of poisoning. | 2001 Jan |
|
Major changes in human ocular UV protection with age. | 2001 Jan |
|
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol. | 2001 Jan |
|
Up-regulation of hepatic IGFBP-1 production as a strategy for preventing benign prostatic hyperplasia. | 2001 Jan |
|
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. | 2001 Jan |
|
Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. | 2001 Jan |
|
Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. | 2001 Jan |
|
A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue. | 2001 Jan |
|
Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. | 2001 Jan |
|
DNA supercoiling-dependent transcriptional coupling between the divergently transcribed promoters of the ilvYC operon of Escherichia coli is proportional to promoter strengths and transcript lengths. | 2001 Jan |
|
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. | 2001 Jan |
|
Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. | 2001 Jan |
|
Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. | 2001 Jan |
|
Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. | 2001 Jan |
|
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. | 2001 Jan |
|
Glycosaminoglycan synthesis and secretion by the retinal pigment epithelium: polarized delivery of hyaluronan from the apical surface. | 2001 Jan |
|
Preparation and characterization of chitin beads as a wound dressing precursor. | 2001 Jan |
|
Structural and conformational properties of (Z)-beta-(1-naphthyl)- dehydroalanine residue. | 2001 Jan |
|
Biochemical characterization and mechanism of action of a thermostable beta-glucosidase purified from Thermoascus aurantiacus. | 2001 Jan 1 |
|
On the diagnosis of hypoglycemia in car drivers--including a review of the literature. | 2001 Jan 1 |
|
Expression of a cytoplasmic transhydrogenase in Saccharomyces cerevisiae results in formation of 2-oxoglutarate due to depletion of the NADPH pool. | 2001 Jan 15 |
|
Morphometric assessment of testicular changes in drug-related fatalities. | 2001 Jan 15 |
|
Microparticles of soy lecithin formed by supercritical processes. | 2001 Jan 20 |
|
Energetics of growth and penicillin production in a high-producing strain of Penicillium chrysogenum. | 2001 Jan 20 |
|
The transcriptional activator Cat8p provides a major contribution to the reprogramming of carbon metabolism during the diauxic shift in Saccharomyces cerevisiae. | 2001 Jan 5 |
|
Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases. | 2001 Jan 5 |
|
Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. | 2001 Jan 5 |
|
Laryngeal carcinoma--epidemiological and clinical features: experience of the Rabin Medical Center in Israel. | 2001 Jan-Feb |
|
Occupational health services for municipal employees. | 2001 Jan-Mar |
|
On the enzymatic activation of NADH. | 2001 Mar 23 |
|
Improved resistance to transition metals of a cobalt-substituted alcohol dehydrogenase 1 from Saccharomyces cerevisiae. | 2001 Nov 17 |
|
Continuous enantioselective esterification of trans-2-phenyl-1-cyclohexanol using a new Candida rugosa lipase in a packed bed bioreactor. | 2001 Nov 17 |
|
Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA. | 2001 Nov 30 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27679397
Primary cultures of cortical neurons obtained from 1-day-old rats were exposed to EtOH after 7days of culture, and viability and morphology were analyzed at structural and ultrastructural levels after 24-h EtOH exposure. EtOH caused a significant reduction of 73±7% in the viability of cultured cortical neurons, by preferentially inducing apoptotic cellular death. This effect was accompanied by an increase in caspase 3 and 9 expression. EtOH induced a reduction in total dendrite length and in the number of dendrites per cell. Ultrastructural studies showed that EtOH increased the number of lipidic vacuoles, lysosomes and multilamellar vesicles and induced a dilated endoplasmatic reticulum lumen and a disorganized Golgi apparatus with a ring-shape appearance. Microtubules showed a disorganized distribution
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:07 GMT 2023
by
admin
on
Fri Dec 15 15:16:07 GMT 2023
|
Record UNII |
3K9958V90M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1293
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
15.1
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QV03AB16
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 862.3050
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
402513
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
EPA PESTICIDE CODE |
1501
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
V03AB16
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QV03AZ01
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
212205
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
361611
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
DSLD |
1152 (Number of products:173)
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QD08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
212505
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
D08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/191
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 862.3040
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
V03AZ01
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
JECFA EVALUATION |
ETHANOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
DSLD |
291 (Number of products:2)
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
746720
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
D08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
NCI_THESAURUS |
C218
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 328.10
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB00898
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
16236
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
3K9958V90M
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL545
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
100000078985
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
C2190
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB11947MIG
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
1310469
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
ALTERNATIVE | |||
|
1076
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
3K9958V90M
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
448
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
64-17-5
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
200-578-6
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
m11495
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
8024-45-1
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
SUPERSEDED | |||
|
8000-16-6
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
SUPERSEDED | |||
|
ALCOHOL, DEHYDRATED
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Description: A colourless, clear and mobile liquid; odour, characteristic.Miscibility: Miscible with water and ether R.Category: Solvent; antiseptic.Storage: Ethanol should be kept in a well-closed container, and stored whenever possible at a temperature between 8 and 15 ?C.Additional information: Ethanol is flammable, burning with a blue smokeless flame. Hygroscopic. Boiling point, about 79 ?C.Requirement: Ethanol contains not less than 98.8% v/v and not more than the equivalent of 100.0% v/v of C2H6O, corresponding to not less than 98.1% m/m and not more than the equivalent of 100.0% m/mof C2H6O. | ||
|
Alcohol
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB13730MIG
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
m5084
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
ETHANOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
D000431
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
702
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB125851
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
ALTERNATIVE | |||
|
30879
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
1012772
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
ALCOHOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Description: A clear, colourless, and mobile liquid; odour, characteristic. Miscibility: Miscible with water, ether R, and glycerol R. Category: Solvent; antiseptic. Storage: Alcohol should be kept in a well-closed container, and stored whenever possible at a temperature between 8 and 15 ?C. Labelling: The designation on the container should state the content of Alcohol in % v/v. Additional information: Different concentrations of Alcohol are prepared from alcohol 96% v/v and water at about 20 ?C.Note: Contraction of volume and rise in temperature occur when mixing Alcohol with water. | ||
|
151
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> INDUCER |
CLINICALLY SIGNIFICANT
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE TOXIC -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|